skip to main content


This content will become publicly available on September 1, 2025

Title: Identifying pathways of pharmaceutical exposure in a mesoconsumer marine fish
Pharmaceutical uptake involves processes that vary across aquatic systems and biota. However, single studies examining multiple environmental compartments, microhabitats, biota, and exposure pathways in mesoconsumer fish are sparse. We investigated the pharmaceutical burden in bonefish (Albula vulpes), pathways of exposure, and estimated exposure to a human daily dose. To evaluate exposure pathways, the number and composition of pharmaceuticals across compartments and the bioconcentration in prey and bonefish were assessed. To evaluate bioaccumulation, we proposed the use of a field-derived bioaccumulation factor (fBAF), due to variability inherent to natural systems. Exposure to a human daily dose was based on bonefish daily energetic requirements and consumption rates using pharmaceutical concentrations in prey. Pharmaceutical number and concentration were highest in prey, followed by bonefish, water and sediment. Fifteen pharmaceuticals were detected in common among bonefish, prey, and water; all of which bioconcentrated in prey and bonefish, and four bioaccumulated in bonefish. The composition of detected pharmaceuticals was compartment specific, and prey were most similar to bonefish. Bonefish were exposed to a maximum of 1.2 % of a human daily dose via prey consumption. Results highlight the need for multicompartment assessments of exposure and consideration of prey along with water as a pathway of exposure.  more » « less
Award ID(s):
2025954 1832229
NSF-PAR ID:
10529198
Author(s) / Creator(s):
; ; ; ; ; ; ; ; ; ; ; ;
Publisher / Repository:
Elsevier
Date Published:
Journal Name:
Journal of Hazardous Materials
Volume:
477
Issue:
C
ISSN:
0304-3894
Page Range / eLocation ID:
135382
Subject(s) / Keyword(s):
Pharmaceutical accumulation Exposure pathways Environmental compartments Human daily dose Marine environments
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Most research on pharmaceutical presence in the environment to date has focused on smaller scale assessments of freshwater and riverine systems, relying mainly on assays of water samples, while studies in marine ecosystems and of exposed biota are sparse. This study investigated the pharmaceutical burden in bonefish (Albula vulpes), an important recreational and artisanal fishery, to quantify pharmaceutical exposure throughout the Caribbean Basin. We sampled 74 bonefish from five regions, and analyzed them for 102 pharmaceuticals. We assessed the influence of sampling region on the number of pharmaceuticals, pharmaceutical assemblage, and risk of pharmacological effects. To evaluate the risk of pharmacological effects at the scale of the individual, we proposed a metric based on the human therapeutic plasma concentration (HTPC), comparing measured concentrations to a threshold of 1/3 the HTPC for each pharmaceutical. Every bonefish had at least one pharmaceutical, with an average of 4.9 and a maximum of 16 pharmaceuticals in one individual. At least one pharmaceutical was detected in exceedance of the 1/3 HTPC threshold in 39% of bonefish, with an average of 0.6 and a maximum of 11 pharmaceuticals exceeding in a Key West individual. The number of pharmaceuticals (49 detected in total) differed across regions, but the risk of pharmacological effects did not (23 pharmaceuticals exceeded the 1/3 HTPC threshold). The most common pharmaceuticals were venlafaxine (43 bonefish), atenolol (36), naloxone (27), codeine (27), and trimethoprim (24). Findings suggest that pharmaceutical detections and concentration may be independent, emphasizing the need to monitor risk to biota regardless of exposure diversity, and to focus on risk quantified at the individual level. This study supports the widespread presence of pharmaceuticals in marine systems and shows the utility of applying the HTPC to assess the potential for pharmacological effects, and thus quantify impact of exposure at large spatial scales. 
    more » « less
  2. To date, the presence of pharmaceuticals has been extensively documented across a wide range of aquatic systems and biota. Further, substantial progress has been made in transitioning from laboratory assessments of pharmaceutical fate and effects in fish to in situ assessments of exposure and effects; however, certain research areas remain understudied. Among these is investigation of differential accumulation across multiple internal tissues in wild marine fish beyond the species commonly sampled in laboratory and freshwater field settings. This study examined the presence of pharmaceuticals across four tissues (plasma, muscle, brain, and liver) in a wild marine fish, bonefish (Albula vulpes), throughout coastal South Florida, USA. Differential accumulation across tissues was assessed for the number and concentration, identity, and composition of accumulated pharmaceuticals by sampling 25 bonefish and analyzing them for 91 pharmaceuticals. The concentration of pharmaceuticals was highest in plasma > liver > brain > muscle, while the number of pharmaceuticals was highest in liver > brain > plasma > muscle. The identity of detected pharmaceuticals was tissue specific, and there was an inverse relationship between the number of detections for each pharmaceutical and its log Kow. The composition of pharmaceuticals was tissue specific for both pharmaceutical presence/absence and concentration. Across all tissues, the greatest similarity was between brain and liver, which were more similar to plasma than to muscle, and muscle was the most distinct tissue. For tissue compositional variability, muscle was the most diverse in accumulated pharmaceuticals, while plasma, brain, and liver were similarly variable. With the highest concentrations in plasma and highest number in liver, and documented variability in accumulated pharmaceuticals across tissues, our results highlight the importance of tissue selection when surveying exposure in wild fish, suggesting that multi-tissue analysis would allow for a more comprehensive assessment of exposure diversity and risk of adverse effects. 
    more » « less
  3. Abstract

    Explosive volcanic eruptions lead to ash deposition and subsequent leaching of contaminants into soils or surface water, impacting flora and fauna, including human health. This study determined the control of ash surface area and chemical composition on ash dissolution rates. Fresh, unhydrated ash samples from four contrasting volcanoes were analyzed in the laboratory. Column leachate tests were used to compare leaching rates over a range of basaltic to andesitic ashes as a function of time and surface area, to analyze the effects of ash deposition. It was found that surface area, measured both geometrically and by multipoint Brunauer‐Emmett‐Teller analysis, generally increases for a short time, gradually decreases, then increases over the rest of the leaching experiment, due to area to mass ratio fluctuations. After the column leachate tests, postleaching water analyses for elemental compositions were conducted by inductively coupled plasma‐mass spectrometry and ion chromatography. Steady state dissolution rates initially decayed rapidly due to the smallest size fraction of ash (dust), which provides a large area of fresh leachable surfaces as well as the rapid dissolution of highly soluble metal salts. Some of the dissolved concentrations of elements relevant to human and ecosystem health such as F, Cd, Se, As, and Cr rose above World Health Organization (WHO) drinking water standards within an hour of experimental leaching. In nature, however, safe consumption standards are further dependent upon bioaccumulation and chronic exposure. As such, individual and recurring ash deposition events have applications to emergency response and preparedness in volcanic regions.

     
    more » « less
  4. Despite the significant progress in the development of vaccines, the COVID-19 pandemic still poses difficulty for its control because of many obstacles such as the proper implementation of vaccination, public hesitancy towards vaccines, dropping out from the second dose, and varying level of protection after the first and the second doses. In this study, we develop a novel mathematical model of COVID-19 transmission, including two separate vaccinated compartments (first dose and both doses). We parametrize and validate our model using data from Dougherty county of Georgia, USA, one of the most affected counties, where the transmission trend clearly is associated with various policies and public events. We analyze our model for stability of equilibria and persistence of the disease, and formulate expression for reproduction numbers. We estimate that the basic reproduction number in Dougherty county is 1.69, and the effective reproduction number during the study period ranges from 0.26 to 6.36. The number of daily undiagnosed cases peaked at 310 per day, resulting in the maximum number of active infectious individuals to be 2471. Our model predicts that in a high transmission scenario, the vaccination strategies should be combined with other non-pharmaceutical prevention strategies to ensure transmission control. Moreover, our results emphasize that completing both doses of vaccines on time is critical to achieve maximum benefits from the vaccination programs. 
    more » « less
  5. The ocean continues to be a sink for microparticle (MP) pollution, which includes microplastics and other anthropogenic debris. While documentation of MP in marine systems is now common, we lack information on rates of MP ingestion by baleen whales and their prey. We collected and assessed MP loads in zooplankton prey and fecal samples of gray whales ( Eschrichtius robustus ) feeding in coastal Oregon, USA and produced the first estimates of baleen whale MP consumption rates from empirical data of zooplankton MP loads (i.e., not modeled). All zooplankton species examined were documented gray whale prey items ( Atylus tridens, Holmesimysis sculpta, Neomysis rayii ) and contained an average of 4 MP per gram of tissue, mostly of the microfiber morphotype. We extrapolated MP loads in zooplankton prey to estimate the daily MP consumption rates of pregnant and lactating gray whales, which ranged between 6.5 and 21 million MP/day. However, these estimates do not account for MP ingested from ambient water or benthic sediments, which may be high for gray whales given their benthic foraging strategy. We also assessed MP loads in fecal samples from gray whales feeding in the same spatio-temporal area and detected MP in all samples examined, which included microfibers and significantly larger morphotypes than in the zooplankton. We theorize that gray whales ingest MP via both indirect trophic transfer from their zooplankton prey and directly through indiscriminate consumption of ambient MPs when foraging benthically where they consume larger MP morphotypes that have sunk and accumulated on the seafloor. Hence, our estimated daily MP consumption rates for gray whales are likely conservative because they are only based on indirect MP ingestion via prey. Our results improve the understanding of MP loads in marine ecosystems and highlight the need to assess the health impacts of MP consumption on zooplankton and baleen whales, particularly due to the predominance of microfibers in samples, which may be more toxic and difficult to excrete than other MP types. Furthermore, the high estimated rates of MP consumption by gray whales highlights the need to assess health consequences to individuals and subsequent scaled-up effects on population vital rates. 
    more » « less